Insiders Ventyx Biosciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 06/06/2024 am IST			5-day change	1st Jan Change
5.28 ^USD	+6.77%		+7.10%	+113.77%

05/06	Ventyx Biosciences Preclinical Study of Obesity Control Candidate Shows Positive Results	MT
05/06	Ventyx Biosciences, Inc. Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers	CI

Ventyx Biosciences Appoints Matthew Moore as Chief Operating Officer; Shares Rise	16/05	MT
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer	16/05	CI
Ventyx Biosciences, Inc. Announces Resignation of Christopher Krueger as Chief Business Officer, Effective on April 15, 2024	06/04	CI
Ventyx Biosciences, Inc. Announces Executive Changes	23/11	CI
Ventyx Biosciences Insider Sold Shares Worth $1,475,858, According to a Recent SEC Filing	12/23/12	MT
Ventyx Biosciences Insider Sold Shares Worth $873,231, According to a Recent SEC Filing	09/23/09	MT
Ventyx Biosciences Insider Sold Shares Worth $299,933, According to a Recent SEC Filing	05/23/05	MT
Ventyx Biosciences Insider Sold Shares Worth $449,699, According to a Recent SEC Filing	05/23/05	MT
Insider Sell: Ventyx Biosciences	08/23/08	MT
Insider Sell: Ventyx Biosciences	08/23/08	MT
Insider Sell: Ventyx Biosciences	08/23/08	MT
Insider Sell: Ventyx Biosciences	02/23/02	MT
Insider Sell: Ventyx Biosciences	09/23/09	MT
Insider Sell: Ventyx Biosciences	02/23/02	MT
Insider Sell: Ventyx Biosciences	14/23/14	MT
Insider Sell: Ventyx Biosciences	12/23/12	MT
Insider Sell: Ventyx Biosciences	07/23/07	MT
Insider Sell: Ventyx Biosciences	06/23/06	MT
Insider Sell: Ventyx Biosciences	20/23/20	MT
Insider Sell: Ventyx Biosciences	09/23/09	MT

No results for this search